News

Two people discuss an exhibit wall displaying a ceramic mug

Artifacts from a half century of cancer research

MIT Koch Institute

Throughout 2024, the Koch Institute has celebrated 50 years of MIT’s cancer research program and the individuals who have shaped its journey. In honor of this milestone anniversary year, the Koch Institute celebrated the opening of a new exhibition: Object Lessons: Celebrating 50 Years of Cancer Research at MIT in 10 Items. Object Lessons invites the public to explore significant artifacts—from one of the earliest PCR machines, developed in the lab of Nobel laureate H. Robert Horvitz, to Greta, a groundbreaking zebrafish from the lab of Professor Nancy Hopkins—in the half century of discoveries and advancements that have positioned MIT at the forefront of the fight against cancer.  

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Angela Belcher and Paula Hammond win 2024 National Medals of Science, Technology

MIT News

Congratulations to MIT's latest National Medals of Science and Technology laureates, including the Koch Institute's own Angela Belcher and Paula Hammond!

Belcher was honored for her work designing novel materials for applications that include solar cells, batteries, and medical imaging, while Hammond was honored for developing methods for assembling thin films that can be used for drug delivery, wound healing, and many other applications.

Bridging Science and Human Impact

MIT News

Giovanni Traverso, featured on MIT News, reflects on his early passion for molecular genetics and how it shaped his interdisciplinary career focused on improving human health. Leading the Laboratory for Translational Engineering, Giovanni's team is pioneering biomedical technologies that aim to help people.      

Anchored for Action

BioSpace

Ankyra Therapeutics treated its first patient with a tumor deep within the body using ANK-101, following its strong performance treating easily accessible tumors. ANK-101 uses techniques developed in the labs of Dane Wittrup and former KI member Darrell Irvine to keep interleukin-12 anchored in tumors, enhancing immune response while reducing side effects and offering new potential for treating advanced solid tumors.

Pumped for Progress  

MIT News

Traditional gastric balloons used for weight loss often lose effectiveness as the body adapts to their presence. Giovanni tackled this challenge by creating a wearable pump that adjusts the balloon’s size, allowing it to expand before meals to curb appetite, and deflate afterward. This study, published in Device, reduced daily food intake by 60% in animals.  

Daré-ing to Revolutionize Treatment

Globe Newswire

Daré Bioscience has received funding to advance DARE-LARC1, a contraceptive device adapted from technology originally developed in the Cima and Langer Labs. The device was previously tested in osteoporosis patients and offers precision dosing over extended delivery periods, with potential applications in reproductive health, obesity, and diabetes and other conditions requiring precise and prolonged treatment.
 

Artifacts from a half century of cancer research

MIT Koch Institute

Throughout 2024, the Koch Institute has celebrated 50 years of MIT’s cancer research program and the individuals who have shaped its journey. In honor of this milestone anniversary year, the Koch Institute celebrated the opening of a new exhibition: Object Lessons: Celebrating 50 Years of Cancer Research at MIT in 10 Items. Object Lessons invites the public to explore significant artifacts—from one of the earliest PCR machines, developed in the lab of Nobel laureate H. Robert Horvitz, to Greta, a groundbreaking zebrafish from the lab of Professor Nancy Hopkins—in the half century of discoveries and advancements that have positioned MIT at the forefront of the fight against cancer.  

Jetting Toward Needle-Free Therapies  

MIT News

Inspired by squids, Giovanni and his team have created a jet-propelled capsule that delivers large-molecule drugs, such as insulin and RNA, directly into the GI tract without the need for needles. This study, published in Nature, shows that the device is as effective as injections. It offers a promising alternative to conventional drug delivery methods, particularly for diabetes and other conditions requiring regular injections.  

Introducing the 2024-2025 Convergence Scholars

MIT Koch Institute

The Koch Institute is pleased to announce the 2024-2025 class of Convergence Scholars. Founded in 2017, the program is designed to enhance the career development of aspiring independent scientists with diverse interests across academia, industry, science communication, and STEM outreach. This year's scholars are Amy Lee (Langer/Jaklenec Lab), Jose Ortiz (Yilmaz Lab), Meaghan McGeary (Jacks Lab), Ranjan Mishra (Weinberg Lab), Yuang Chen (Anderson Lab), and Zhengpeng (Jason) Wan (Kamm Lab).

Lumicell lights the way to better patient outcomes

MIT News

Residual cancer cells can lead to costly and invasive additional treatments, drive disease relapse and progression, and worsen patient quality of life and survival. Lumicell has developed a cost effective, real-time imaging system for eliminating even single residual cancer cells during surgery and will greatly improve patient outcomes. Piloted with seed funding from the Koch Institute Frontier Research Program, the technology was FDA-approved earlier this year.

Rhoda Zhang Wins 2024 Collegiate Inventors Competition

MIT News

Graduate student Linzixuan (Rhoda) Zhang has won the 2024 Collegiate Inventors Competition in both the Graduate and People's Choice categories. With advisors Robert Langer and Ana Jaklenec, Zhang and KI postdoc Xin Yang are developing metal-organic frameworks and other safe, sustainable nutrient stabilizing materials to address global micronutrient deficiencies. They are also launching MOFe™ Coffee, the first iron-fortified coffee.